X-linked adrenoleukodystrophy (X-ALD) is a debilitating disease caused by mutations in the ABCD1 gene. Approximately 30% of affected boys develop the progressive ...

Viking Therapeutics has announced positive results from its Phase Ib clinical trial of VK0214, a thyroid hormone receptor ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

X-Linked Adrenoleukodystrophy (ALD) is a rare genetic disorder that breaks down myelin, the protective sheath that surrounds the brain and spinal cord. Early intervention and regular screenings ...

Considering taking supplements to treat adrenoleukodystrophy ald? Below is a list of common natural remedies used to treat or reduce the symptoms of adrenoleukodystrophy ald. Follow the links to ...

When William was days old, he was diagnosed with adrenoleukodystrophy — or ALD — a rare genetic disease affecting one in 17,000 people.

Inc. (NASDAQ: BLUE) ("bluebird") today announced that it has entered into a definitive agreement to be acquired by funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners ...